Article info
PDFOriginal research
Chemotherapy response score as a prognostic tool in patients with advanced stage endometrial carcinoma treated with neoadjuvant chemotherapy
- Correspondence to Dr Katherine C Kurnit, Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA; kkurnit{at}bsd.uchicago.edu
Citation
Chemotherapy response score as a prognostic tool in patients with advanced stage endometrial carcinoma treated with neoadjuvant chemotherapy
Publication history
- Received November 2, 2020
- Revision received March 18, 2021
- Accepted March 22, 2021
- First published April 8, 2021.
Article Versions
- You are currently viewing a Previous version of this article (7 June 2021).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.